TSX:HHL Holdings Information

TSX:HHL is an equity ETF with a total of 24 individual holdings. The top holdings are Bristol-Myers Squibb Company stock at 5.38%, Merck & Co. at 5.34%, Novartis AG ADR at 5.31%, AstraZeneca at 5.25%, and Johnson & Johnson at 5.21%.

Total Holdings

Top 10 Percentage

51.22%

Asset Class

Equity

ETF Category

Health Care

Assets

1.64B

PE Ratio

21.81

Sector Allocation

Top 25 Holdings

No.	Symbol	Name	% Weight	Shares
1	BMY	Bristol-Myers Squibb Company	5.38%	1,274,460
2	MRK	Merck & Co., Inc.	5.34%	647,961
3	NVSN.MX	Novartis AG ADR	5.31%	492,014
4	AZN	AstraZeneca PLC	5.25%	728,863
5	JNJ	Johnson & Johnson	5.21%	321,375
6	DHR	Danaher Corporation	5.01%	279,688
7	ELV	Elevance Health, Inc.	5.00%	182,016
8	REGN	Regeneron Pharmaceuticals, Inc.	4.94%	81,748
9	AMGN	Amgen Inc.	4.90%	191,147
10	TMO	Thermo Fisher Scientific Inc.	4.88%	107,571
11	LLY	Eli Lilly and Company	4.88%	57,993
12	MDT	Medtronic plc	4.84%	644,040
13	ABBV	AbbVie Inc.	4.82%	269,386
14	ISRG	Intuitive Surgical, Inc.	4.81%	108,497
15	ABT	Abbott Laboratories	4.72%	481,458
16	SYK	Stryker Corporation	4.52%	164,367
17	UNH	UnitedHealth Group Incorporated	4.51%	174,495
18	BSX	Boston Scientific Corporation	4.46%	597,341
19	A	Agilent Technologies, Inc.	4.35%	407,816
20	ZTS	Zoetis Inc.	4.10%	416,270
21	n/a	Foreign Currency Forwards	1.35%	n/a
22	n/a	Harvest Canadian T Bill Etp	0.90%	314,561
23	n/a	Cash And Other Net Assets And Liabilities	0.84%	n/a
24	n/a	Written Call Options	-0.32%	n/a

As of Dec 31, 2025